BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 3873156)

  • 1. Hemodynamic effects of nifedipine on secondary pulmonary hypertension in man.
    Garzaniti N; el Allaf D; D'Orio V; Cremers S; Marcelle R; Carlier J
    Acta Cardiol; 1985; 40(2):207-15. PubMed ID: 3873156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodynamic effects of nifedipine versus hydralazine in primary pulmonary hypertension.
    Fisher J; Borer JS; Moses JW; Goldberg HL; Niarchos AP; Whitman HH; Mermelstein M
    Am J Cardiol; 1984 Sep; 54(6):646-50. PubMed ID: 6475787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of nifedipine, verapamil, and diltiazem on experimental pulmonary hypertension.
    Young TE; Lundquist LJ; Chesler E; Weir EK
    Am J Cardiol; 1983 Jan; 51(1):195-200. PubMed ID: 6571766
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemodynamic effects of nifedipine in pulmonary hypertension.
    Klugmann S; Salvi A; Fioretti P; Camerini F
    G Ital Cardiol; 1982; 12(7):505-8. PubMed ID: 7169146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Variable hemodynamic response to nifedipine in pulmonary hypertension secondary to chronic obstructive bronchopathy and pulmonary fibrosis].
    Domenighetti G
    Schweiz Med Wochenschr; 1985 Sep; 115(39):1345-7. PubMed ID: 4071009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute hemodynamic effects of nifedipine in infants with bronchopulmonary dysplasia and pulmonary hypertension.
    Brownlee JR; Beekman RH; Rosenthal A
    Pediatr Res; 1988 Aug; 24(2):186-90. PubMed ID: 3186330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and long term effect of nifedipine on pulmonary hypertension secondary to chronic obstructive airways disease.
    Johnson DC; Joshi RC; Mehta R; Cunnington AR
    Eur J Respir Dis Suppl; 1986; 146():495-502. PubMed ID: 3465575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adverse hemodynamic and clinical effects of calcium channel blockade in pulmonary hypertension secondary to obliterative pulmonary vascular disease.
    Packer M; Medina N; Yushak M
    J Am Coll Cardiol; 1984 Nov; 4(5):890-901. PubMed ID: 6491082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nifedipine attenuates acute hypoxic pulmonary vasoconstriction in patients with chronic obstructive pulmonary disease.
    Burghuber OC
    Respiration; 1987; 52(2):86-93. PubMed ID: 3671896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nifedipine in pulmonary arterial hypertension. Importance of Raynaud's phenomenon.
    Fisher J; Mack RJ; Likier HM; Schiff AN; Borer JS
    Chest; 1987 Sep; 92(3):400-5. PubMed ID: 3622018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hemodynamic effects of sublingual nifedipine in acute myocardial infarction.
    Gordon GD; Mabin TA; Isaacs S; Lloyd EA; Eichler HG; Opie LH
    Am J Cardiol; 1984 May; 53(9):1228-32. PubMed ID: 6143505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of nifedipine on hemodynamics in precapillary pulmonary hypertension at rest and during exertion].
    Gassner A; Pichler M; Fridrich L; Sykora J; Tizek H; Lenz K
    Dtsch Med Wochenschr; 1983 Nov; 108(47):1790-4. PubMed ID: 6641530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative actions of hydralazine, nifedipine and amrinone in primary pulmonary hypertension.
    Rich S; Ganz R; Levy PS
    Am J Cardiol; 1983 Nov; 52(8):1104-7. PubMed ID: 6637831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute haemodynamic effects of nifedipine in patients with ventricular septal defect.
    Berisha S; Goda A; Kastrati A; Frasheri A; Popa Y
    Br Heart J; 1988 Aug; 60(2):149-55. PubMed ID: 3415874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
    Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV
    Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of nifedipine on physiologic shunting and oxygenation in chronic obstructive pulmonary disease.
    Kalra L; Bone MF
    Am J Med; 1993 Apr; 94(4):419-23. PubMed ID: 8475936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined hemodynamic effects of nifedipine and nitroglycerin in congestive heart failure.
    Kubo SH; Fox SC; Prida XE; Cody RJ
    Am Heart J; 1985 Nov; 110(5):1032-4. PubMed ID: 3933315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and long-term effects of nifedipine on pulmonary and systemic hemodynamics in patients with pulmonary hypertension associated with diffuse systemic sclerosis, the CREST syndrome and mixed connective tissue disease.
    Alpert MA; Pressly TA; Mukerji V; Lambert CR; Mukerji B; Panayiotou H; Sharp GC
    Am J Cardiol; 1991 Dec; 68(17):1687-91. PubMed ID: 1746473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-week nifedipine treatment for pulmonary hypertension complicating chronic obstructive lung disease.
    Saadjian A; Philip-Joet F; Guintoli A; Torresani J; Arnaud A
    Eur J Respir Dis; 1985 Nov; 67(5):346-50. PubMed ID: 4085586
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nifedipine reduces pulmonary pressure and vascular tone during short- but not long-term treatment of pulmonary hypertension in patients with chronic obstructive pulmonary disease.
    Agostoni P; Doria E; Galli C; Tamborini G; Guazzi MD
    Am Rev Respir Dis; 1989 Jan; 139(1):120-5. PubMed ID: 2912331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.